dabigatran etexilate
Generic: dabigatran etexilate
Labeler: camber pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
dabigatran etexilate
Generic Name
dabigatran etexilate
Labeler
camber pharmaceuticals, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
dabigatran etexilate mesylate 75 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
31722-621
Product ID
31722-621_3b236998-0037-d34f-e063-6294a90a03f5
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207961
Listing Expiration
2026-12-31
Marketing Start
2020-05-06
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
31722621
Hyphenated Format
31722-621
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
dabigatran etexilate (source: ndc)
Generic Name
dabigatran etexilate (source: ndc)
Application Number
ANDA207961 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 75 mg/1
Packaging
- 10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK
- 60 CAPSULE in 1 BOTTLE (31722-621-60)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3b236998-0037-d34f-e063-6294a90a03f5", "openfda": {"upc": ["0331722621601", "0331722622608", "0331722666602"], "unii": ["SC7NUW5IIT"], "rxcui": ["1037045", "1037179", "1723476"], "spl_set_id": ["3c24e235-218b-438e-9456-42c18ff01913"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BLISTER PACK in 1 CARTON (31722-621-32) / 6 CAPSULE in 1 BLISTER PACK", "package_ndc": "31722-621-32", "marketing_start_date": "20250203"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (31722-621-60)", "package_ndc": "31722-621-60", "marketing_start_date": "20200506"}], "brand_name": "Dabigatran Etexilate", "product_id": "31722-621_3b236998-0037-d34f-e063-6294a90a03f5", "dosage_form": "CAPSULE", "pharm_class": ["Direct Thrombin Inhibitor [EPC]", "Thrombin Inhibitors [MoA]"], "product_ndc": "31722-621", "generic_name": "Dabigatran Etexilate", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dabigatran Etexilate", "active_ingredients": [{"name": "DABIGATRAN ETEXILATE MESYLATE", "strength": "75 mg/1"}], "application_number": "ANDA207961", "marketing_category": "ANDA", "marketing_start_date": "20200506", "listing_expiration_date": "20261231"}